Literature DB >> 26139602

Cyclin-dependent kinase-mediated Sox2 phosphorylation enhances the ability of Sox2 to establish the pluripotent state.

Juan Ouyang1, Wei Yu2, Jing Liu3, Nian Zhang2, Laurence Florens2, Jiekai Chen3, He Liu3, Michael Washburn4, Duanqing Pei5, Ting Xie6.   

Abstract

Sox2 is a key factor in maintaining self-renewal of embryonic stem cells (ESCs) and adult stem cells as well as in reprogramming differentiated cells back into pluripotent or multipotent stem cells. Although previous studies have shown that Sox2 is phosphorylated in human ESCs, the biological significance of Sox2 phosphorylation in ESC maintenance and reprogramming has not been well understood. In this study we have identified new phosphorylation sites on Sox2 and have further demonstrated that Cdk2-mediated Sox2 phosphorylation at Ser-39 and Ser-253 is required for establishing the pluripotent state during reprogramming but is dispensable for ESC maintenance. Mass spectrometry analysis of purified Sox2 protein has identified new phosphorylation sites on two tyrosine and six serine/Threonine residues. Cdk2 physically interacts with Sox2 and phosphorylates Sox2 at Ser-39 and Ser-253 in vitro. Surprisingly, Sox2 phosphorylation at Ser-39 and Ser-253 is dispensable for ESC self-renewal and cell cycle progression. In addition, Sox2 phosphorylation enhances its ability to establish the pluripotent state during reprogramming by working with Oct4 and Klf4. Finally, Cdk2 can also modulate the ability of Oct4, Sox2, and Klf4 in reprogramming fibroblasts back into pluripotent stem cells. Therefore, this study has for the first time demonstrated that Sox2 phosphorylation by Cdk2 promotes the establishment but not the maintenance of the pluripotent state. It might also help explain why the inactivation of CDK inhibitors such as p53, p21, and Arf/Ink4 promotes the induction of pluripotent stem cells.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell cycle; cyclin-dependent kinase (CDK); induced pluripotent stem cell (iPS cell) (iPSC); phosphorylation; pluripotency; protein phosphorylation; reprograming; reprogramming; self-renewal

Mesh:

Substances:

Year:  2015        PMID: 26139602      PMCID: PMC4566249          DOI: 10.1074/jbc.M115.658195

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins.

Authors:  Ying Zhang; Zhihui Wen; Michael P Washburn; Laurence Florens
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

Review 2.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 3.  Sox2 roles in neural stem cells.

Authors:  Larysa H Pevny; Silvia K Nicolis
Journal:  Int J Biochem Cell Biol       Date:  2009-09-03       Impact factor: 5.085

4.  Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells.

Authors:  Zuzana Koledova; Leona Raskova Kafkova; Lenka Calabkova; Vladimir Krystof; Petr Dolezel; Vladimir Divoky
Journal:  Stem Cells Dev       Date:  2010-02       Impact factor: 3.272

5.  Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics.

Authors:  Jiekai Chen; Jing Liu; You Chen; Jiaqi Yang; Jing Chen; He Liu; Xiangjie Zhao; Kunlun Mo; Hong Song; Lin Guo; Shilong Chu; Deping Wang; Ke Ding; Duanqing Pei
Journal:  Cell Res       Date:  2011-03-29       Impact factor: 25.617

Review 6.  The regulation of INK4/ARF in cancer and aging.

Authors:  William Y Kim; Norman E Sharpless
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

7.  Phosphorylation dynamics during early differentiation of human embryonic stem cells.

Authors:  Dennis Van Hoof; Javier Muñoz; Stefan R Braam; Martijn W H Pinkse; Rune Linding; Albert J R Heck; Christine L Mummery; Jeroen Krijgsveld
Journal:  Cell Stem Cell       Date:  2009-08-07       Impact factor: 24.633

8.  A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

Authors:  J K Holmes; M J Solomon
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

9.  Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.

Authors:  Yuanji Lin; Ying Yang; Weihua Li; Qi Chen; Jie Li; Xiao Pan; Lina Zhou; Changwei Liu; Chunsong Chen; Jianqin He; Hongcui Cao; Hangping Yao; Li Zheng; Xiaowei Xu; Zongping Xia; Jiangtao Ren; Lei Xiao; Lanjuan Li; Binghui Shen; Honglin Zhou; Ying-Jie Wang
Journal:  Mol Cell       Date:  2012-10-04       Impact factor: 17.970

10.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

View more
  20 in total

1.  G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells.

Authors:  Lijun Liu; Wojciech Michowski; Hiroyuki Inuzuka; Kouhei Shimizu; Naoe Taira Nihira; Joel M Chick; Na Li; Yan Geng; Alice Y Meng; Alban Ordureau; Aleksandra Kołodziejczyk; Keith L Ligon; Roderick T Bronson; Kornelia Polyak; J Wade Harper; Steven P Gygi; Wenyi Wei; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2017-02-13       Impact factor: 28.824

2.  Mitotic phosphorylation of SOX2 mediated by Aurora kinase A is critical for the stem-cell like cell maintenance in PA-1 cells.

Authors:  Dandan Qi; Qianqian Wang; Min Yu; Rongfeng Lan; Shuiming Li; Fei Lu
Journal:  Cell Cycle       Date:  2016-06-01       Impact factor: 4.534

Review 3.  The cell cycle in stem cell proliferation, pluripotency and differentiation.

Authors:  Lijun Liu; Wojciech Michowski; Aleksandra Kolodziejczyk; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2019-09-02       Impact factor: 28.824

Review 4.  Cellular functions of stem cell factors mediated by the ubiquitin-proteasome system.

Authors:  Jihye Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

Review 5.  Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target.

Authors:  Siwanon Jirawatnotai; Stephen Dalton; Methichit Wattanapanitch
Journal:  Semin Cell Dev Biol       Date:  2020-05-14       Impact factor: 7.727

6.  Cyclin-Dependent Kinase-Dependent Phosphorylation of Sox2 at Serine 39 Regulates Neurogenesis.

Authors:  Shuhui Lim; Akshay Bhinge; Sara Bragado Alonso; Irene Aksoy; Julieta Aprea; Chit Fang Cheok; Federico Calegari; Lawrence W Stanton; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

Review 7.  Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks.

Authors:  Ben Boward; Tianming Wu; Stephen Dalton
Journal:  Stem Cells       Date:  2016-03-16       Impact factor: 6.277

Review 8.  Crosstalk between stem cell and cell cycle machineries.

Authors:  Michael S Kareta; Julien Sage; Marius Wernig
Journal:  Curr Opin Cell Biol       Date:  2015-11-11       Impact factor: 8.382

9.  CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.

Authors:  Dinoop Ravindran Menon; Yuchun Luo; John J Arcaroli; Sucai Liu; Lekha Nair KrishnanKutty; Douglas G Osborne; Yang Li; Jenny Mae Samson; Stacey Bagby; Aik-Choon Tan; William A Robinson; Wells A Messersmith; Mayumi Fujita
Journal:  Cancer Res       Date:  2018-10-08       Impact factor: 12.701

10.  Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.

Authors:  María Soledad Rodríguez Varela; Sofía Mucci; Guillermo Agustín Videla Richardson; Olivia Morris Hanon; Verónica Alejandra Furmento; Santiago Gabriel Miriuka; Gustavo Emilio Sevlever; María Elida Scassa; Leonardo Romorini
Journal:  Cell Cycle       Date:  2018-08-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.